Allele Biotechnology & Pharmaceuticals, Inc. — Form D
Allele Biotechnology & Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-09-12. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-09-12
- Form: D
- Accession: 0001617865-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $7.0M
- Investors: 3
- Date of first sale: 2014-08-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-224595
Issuer
- Name: Allele Biotechnology & Pharmaceuticals, Inc.
- CIK: 0001617865
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Address: 6404 NANCY RIDGE DRIVE, SAN DIEGO, CA, 92121
- Phone: 858-587-6645
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Quishi Fu | Director | San Diego, CA |
| Shao-Chung Tsai | Director | San Diego, CA |
| Jiwu Wang | Director | San Diego, CA |
| Jiwu Wang | Executive Officer | San Diego, CA |
| Robert LaPolla | Director | San Diego, CA |
| Lin Yang | Executive Officer | San Diego, CA |
Other filings by this issuer (1)
More